Literature DB >> 9192982

Evidence for divergence of DNA copy number changes in serous, mucinous and endometrioid ovarian carcinomas.

J Tapper1, R Bützow, T Wahlström, M Seppälä, S Knuutila.   

Abstract

Comparative genomic hybridization was applied to detect and map changes in DNA copy number in 24 well or moderately differentiated epithelial ovarian carcinomas (eight serous, eight mucinous and eight endometrioid carcinomas). Twenty-three of the 24 tumours showed changes in DNA copy number in one or several regions (median 4, range 1-17). Gains were more frequent than losses (ratio 1.6:1.0). The most frequent gains occurred in chromosomes 1q (38%), 2p (29%), 7q (25%), 8q(38%) and 17q (38%), and the most common losses were located in chromosomes 8p (21%), 9p (25%) and 13q (21%). High-level amplifications were detected in seven tumours at 1q22-32, 2p15-22, 3qcen-23, 6p21-22 and 8q. In the three histological subtypes the copy number karyotypes showed substantial differences. Gains at 1q were observed in endometrioid (five cases) and serous tumours (four cases). Increased copy number at 10q was seen in endometrioid tumours only (four cases), whereas gains at 11q occurred mostly in serous tumours (four cases). In mucinous tumours, the most common copy number change was a gain at 17q (six cases). The results show that, in epithelial ovarian carcinoma, changes in DNA copy number are a rule rather than an exception, chromosomes 1, 2, 7, 8, 9, 13 and 17 being the most frequently affected. The diverging pattern of genetic changes seen in epithelial ovarian carcinomas with different histological phenotypes suggests that various pathways may lead to tumorigenesis and/or progression in these subgroups.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9192982      PMCID: PMC2223609          DOI: 10.1038/bjc.1997.304

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  31 in total

1.  Overexpression and mutation of p53 in epithelial ovarian cancer.

Authors:  J R Marks; A M Davidoff; B J Kerns; P A Humphrey; J C Pence; R K Dodge; D L Clarke-Pearson; J D Iglehart; R C Bast; A Berchuck
Journal:  Cancer Res       Date:  1991-06-01       Impact factor: 12.701

2.  Distinction of low grade from high grade human ovarian carcinomas on the basis of losses of heterozygosity on chromosomes 3, 6, and 11 and HER-2/neu gene amplification.

Authors:  J P Zheng; W R Robinson; T Ehlen; M C Yu; L Dubeau
Journal:  Cancer Res       Date:  1991-08-01       Impact factor: 12.701

3.  Overrepresentation of 3q and 8q material and loss of 18q material are recurrent findings in advanced human ovarian cancer.

Authors:  N Arnold; L Hagele; L Walz; W Schempp; J Pfisterer; T Bauknecht; M Kiechle
Journal:  Genes Chromosomes Cancer       Date:  1996-05       Impact factor: 5.006

4.  K-ras activation in neoplasms of the human female reproductive tract.

Authors:  T Enomoto; M Inoue; A O Perantoni; N Terakawa; O Tanizawa; J M Rice
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

5.  Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1.

Authors:  H Tsuda; S Hirohashi; Y Shimosato; T Hirota; S Tsugane; H Yamamoto; N Miyajima; K Toyoshima; T Yamamoto; J Yokota
Journal:  Cancer Res       Date:  1989-06-01       Impact factor: 12.701

6.  Cytogenetic studies in ovarian cancer.

Authors:  J Whang-Peng; T Knutsen; E C Douglass; E Chu; R F Ozols; W M Hogan; R C Young
Journal:  Cancer Genet Cytogenet       Date:  1984-01

7.  Chromosome aberrations in 35 primary ovarian carcinomas.

Authors:  T Pejovic; S Heim; N Mandahl; B Baldetorp; B Elmfors; U M Flodérus; S Furgyik; G Helm; A Himmelmann; H Willén
Journal:  Genes Chromosomes Cancer       Date:  1992-01       Impact factor: 5.006

8.  Fine-scale deletion mapping of the distal long arm of chromosome 6 in 70 human ovarian cancers.

Authors:  S Saito; H Saito; S Koi; S Sagae; R Kudo; J Saito; K Noda; Y Nakamura
Journal:  Cancer Res       Date:  1992-10-15       Impact factor: 12.701

9.  Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer.

Authors:  A Berchuck; A Kamel; R Whitaker; B Kerns; G Olt; R Kinney; J T Soper; R Dodge; D L Clarke-Pearson; P Marks
Journal:  Cancer Res       Date:  1990-07-01       Impact factor: 12.701

10.  Protooncogene amplification and tumor ploidy in human ovarian neoplasms.

Authors:  H Sasano; C T Garrett; D S Wilkinson; S Silverberg; J Comerford; J Hyde
Journal:  Hum Pathol       Date:  1990-04       Impact factor: 3.466

View more
  13 in total

1.  Somatic mutations of the PPP2R1B candidate tumor suppressor gene at chromosome 11q23 are infrequent in ovarian carcinomas.

Authors:  R Wu; D C Connolly; X Ren; E R Fearon; K R Cho
Journal:  Neoplasia       Date:  1999-10       Impact factor: 5.715

2.  Allelic analysis of serous ovarian carcinoma reveals two putative tumor suppressor loci at 18q22-q23 distal to SMAD4, SMAD2, and DCC.

Authors:  H Lassus; R Salovaara; L A Aaltonen; R Butzow
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

Review 3.  Ovarian cancer.

Authors:  Kathleen R Cho; Ie-Ming Shih
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

Review 4.  DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies.

Authors:  S Knuutila; A M Björkqvist; K Autio; M Tarkkanen; M Wolf; O Monni; J Szymanska; M L Larramendy; J Tapper; H Pere; W El-Rifai; S Hemmer; V M Wasenius; V Vidgren; Y Zhu
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

5.  Paracrine SLPI secretion upregulates MMP-9 transcription and secretion in ovarian cancer cells.

Authors:  Ebony Hoskins; Jaime Rodriguez-Canales; Stephen M Hewitt; Wafic Elmasri; Jasmine Han; Shing Han; Ben Davidson; Elise C Kohn
Journal:  Gynecol Oncol       Date:  2011-06-14       Impact factor: 5.482

6.  Novel DNA amplification on chromosomes 2p25.3 and 7q11.23 in cholangiocarcinoma identified by arbitrarily primed polymerase chain reaction.

Authors:  S Chariyalertsak; T Khuhaprema; V Bhudisawasdi; B Sripa; S Wongkham; S Petmitr
Journal:  J Cancer Res Clin Oncol       Date:  2005-11-15       Impact factor: 4.322

7.  Genetic alterations and protein expression of KIT and PDGFRA in serous ovarian carcinoma.

Authors:  H Lassus; H Sihto; A Leminen; S Nordling; H Joensuu; N N Nupponen; R Butzow
Journal:  Br J Cancer       Date:  2004-12-13       Impact factor: 7.640

Review 8.  Comparative genomic hybridization and chromosomal instability in solid tumours.

Authors:  P H Rooney; G I Murray; D A Stevenson; N E Haites; J Cassidy; H L McLeod
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

9.  Cytogenetic alterations in ovarian clear cell carcinoma detected by comparative genomic hybridisation.

Authors:  J Dent; G D Hall; N Wilkinson; T J Perren; I Richmond; A F Markham; H Murphy; S M Bell
Journal:  Br J Cancer       Date:  2003-05-19       Impact factor: 7.640

10.  Rescue karyotyping: a case series of array-based comparative genomic hybridization evaluation of archival conceptual tissue.

Authors:  Rashmi Kudesia; Marilyn Li; Janice Smith; Ankita Patel; Zev Williams
Journal:  Reprod Biol Endocrinol       Date:  2014-03-03       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.